NUCB2 and renal cell carcinoma: In the overall analysis, there was no significant association in the expression of nesfatin-1 in localised early-stage (OR = 0.09, 95% CI = −0.12–0.29, p = 0.41) and late-stage (OR = 0.36, 95% CI = 0.07–1.89, p = 0.23) RCC, respectively (Figure 2A,B).